Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Other Operating Expenses (2021 - 2025)

Lucid Diagnostics' Other Operating Expenses history spans 5 years, with the latest figure at $7.3 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 16.83% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $24.8 million, up 2.27%, while the annual FY2025 figure was $24.8 million, 2.27% up from the prior year.
  • Other Operating Expenses reached $7.3 million in Q4 2025 per LUCD's latest filing, up from $6.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $15.8 million in Q4 2021 to a low of -$12.5 million in Q1 2022.
  • Average Other Operating Expenses over 5 years is $4.8 million, with a median of $6.0 million recorded in 2023.
  • The largest YoY upside for Other Operating Expenses was 470.72% in 2022 against a maximum downside of 241.06% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $15.8 million in 2021, then crashed by 54.92% to $7.1 million in 2022, then decreased by 10.73% to $6.4 million in 2023, then dropped by 1.81% to $6.3 million in 2024, then grew by 16.83% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Other Operating Expenses are $7.3 million (Q4 2025), $6.1 million (Q3 2025), and $5.7 million (Q2 2025).